News from tianyin pharmaceutical co., inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 11, 2016, 04:05 ET TPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing Requirements

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI) (the "Company"), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized ...

Jul 30, 2015, 04:05 ET TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI) (the "Company"), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized ...

May 26, 2015, 01:46 ET TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional...

Apr 22, 2015, 08:18 ET TPI Holds Annual Meeting of Shareholders on May 25, 2015 at Chengdu, China

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Feb 26, 2015, 04:01 ET TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements

Tianyin Pharmaceutical Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional...

Feb 17, 2015, 02:55 ET JCM Plans for FDA certification Process for International Business Development

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical...

Feb 06, 2015, 10:53 ET TPI to Form Strategic Alliance with Buchang Pharma

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Jan 23, 2015, 03:03 ET TPI's JCM Updates on Import Registration for International Clients

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical...

Jan 20, 2015, 07:30 ET TPI QLF Received GMP Certification

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Jan 14, 2015, 11:26 ET TPI to Form Strategic Alliance with Buchang Pharma

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Jan 12, 2015, 11:50 ET TPI Initiates the Official Relocation Process to Qionglai Tianyin Facility (QLF)

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Jan 06, 2015, 06:36 ET Buchang Pharmaceutical Visits Tianyin Qionglai Facility

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Jan 02, 2015, 11:42 ET TPI Updates on Alliance Discussion

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Dec 10, 2014, 04:38 ET TPI Reports Fiscal Year 2014 Financial Results

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional...

Dec 02, 2014, 07:00 ET TPI Updates on its New Facility GMP Certification Progress and Growth Strategies

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Oct 23, 2014, 08:34 ET TPI's QLF Updates on its GMP Certification Progress

Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Oct 21, 2014, 02:09 ET Tianyin Pharmaceutical Received Notices of Non-Compliance from NYSE MKT

Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the "Company"), a pharmaceutical company that specializes in the development and sale of patented...

Oct 15, 2014, 11:33 ET Tianyin Pharmaceutical Provides Update on Filing of Form 10-K for Fiscal Year Ended June 30, 2014

Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the "Company"), a pharmaceutical company that specializes in the development and sale of patented...

Sep 29, 2014, 09:54 ET TPI's QLF Completes GMP site inspection by CFDA

Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Sep 09, 2014, 09:00 ET JCM Applies for Azithromycin API Import Certificate at India

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical...

Aug 28, 2014, 12:10 ET TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF)

Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Aug 18, 2014, 08:30 ET Qionglai Facility (QLF) Schedules September for GMP Examination

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Aug 04, 2014, 03:11 ET Testing Runs Progress Updates for TPI's Qionglai Facility

Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Jul 14, 2014, 09:51 ET TPI Targets Early August 2014 to Start Qionglai Facility (QLF) GMP Inspection

Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional...

Jul 07, 2014, 08:53 ET TPI Receives GMP for Tablets Formulation in Early July

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical...